1. Epidemiology of heart failure in myocardial infarction treated with primary angioplasty: Analysis of the Codi IAM registry
- Author
-
Aleix Fort, Julio Martí-Almor, Lluís Recasens, Helena Tizón-Marcos, María Grau, Josep Comín-Colet, Beatriz Vaquerizo, Núria Farré, Ramon Serrat, and Laia Carla Belarte-Tornero
- Subjects
medicine.medical_specialty ,education.field_of_study ,Ejection fraction ,business.industry ,medicine.medical_treatment ,Cardiogenic shock ,Population ,Percutaneous coronary intervention ,medicine.disease ,surgical procedures, operative ,Heart failure ,Internal medicine ,Epidemiology ,Conventional PCI ,medicine ,Cardiology ,cardiovascular diseases ,Myocardial infarction ,Cardiology and Cardiovascular Medicine ,business ,education - Abstract
Introduction and objectives The epidemiology of heart failure (HF) that complicates ST-segment elevation myocardial infarction (STEMI) is not well defined. Our aim was to analyze the epidemiology and prognosis of HF that complicates STEMI treated with primary percutaneous coronary intervention (PCI). Methods Multicentre registry of 14 070 patients with STEMI treated with primary PCI from January 2010 to December 2015. Results Patients with HF were older, more frequently female, and diabetic and had chronic ischaemic heart disease. Only 10.3% of patients with STEMI treated with primary PCI had HF on admission and the majority of them had the mildest form (Killip–Kimball II 77.8%). HF was associated with high mortality (30-day mortality was 2.9% of patients in Killip–Kimball I, 9.5% of Killip–Kimball II and 17.4% in Killip–Kimball III, P Conclusions HF complicates 10.3% of patients with STEMI treated with primary PCI and it was associated with a higher risk of developing cardiogenic shock and with 30-day and 1-year mortality in 30-day survivors. In this high-risk population, primary PCI and posterior medical treatment should be prioritized to avoid worsening of HF.
- Published
- 2019
- Full Text
- View/download PDF